vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and GOLAR LNG LTD (GLNG). Click either name above to swap in a different company.

GOLAR LNG LTD is the larger business by last-quarter revenue ($122.5M vs $121.8M, roughly 1.0× Core Laboratories Inc.). GOLAR LNG LTD runs the higher net margin — 25.7% vs 4.2%, a 21.5% gap on every dollar of revenue. On growth, GOLAR LNG LTD posted the faster year-over-year revenue change (89.1% vs -1.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Golar LNG owns and operates marine LNG infrastructure. The company had developed Floating LNG liquefaction terminal (FLNG) and Floating Storage and Regasification Unit (FSRU) projects based on the conversion of existing LNG carriers. Front End Engineering and Design (FEED) studies have now been completed for a larger newbuild FLNG solution. Golar is also collaborating with another industry leader to investigate solutions for the floating production of blue and green ammonia as well as carbon ...

CLB vs GLNG — Head-to-Head

Bigger by revenue
GLNG
GLNG
1.0× larger
GLNG
$122.5M
$121.8M
CLB
Growing faster (revenue YoY)
GLNG
GLNG
+90.5% gap
GLNG
89.1%
-1.4%
CLB
Higher net margin
GLNG
GLNG
21.5% more per $
GLNG
25.7%
4.2%
CLB

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
CLB
CLB
GLNG
GLNG
Revenue
$121.8M
$122.5M
Net Profit
$5.1M
$31.5M
Gross Margin
Operating Margin
1.5%
39.4%
Net Margin
4.2%
25.7%
Revenue YoY
-1.4%
89.1%
Net Profit YoY
190.5%
EPS (diluted)
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
GLNG
GLNG
Q1 26
$121.8M
Q4 25
$138.3M
Q3 25
$134.5M
$122.5M
Q2 25
$130.2M
Q1 25
$123.6M
Q4 24
$129.2M
Q3 24
$134.4M
$64.8M
Q2 24
$130.6M
Net Profit
CLB
CLB
GLNG
GLNG
Q1 26
$5.1M
Q4 25
$4.9M
Q3 25
$14.2M
$31.5M
Q2 25
$10.6M
Q1 25
$-154.0K
Q4 24
$7.4M
Q3 24
$11.7M
$-34.8M
Q2 24
$9.0M
Gross Margin
CLB
CLB
GLNG
GLNG
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
GLNG
GLNG
Q1 26
1.5%
Q4 25
11.5%
Q3 25
15.6%
39.4%
Q2 25
11.7%
Q1 25
3.6%
Q4 24
11.0%
Q3 24
14.7%
-43.7%
Q2 24
12.3%
Net Margin
CLB
CLB
GLNG
GLNG
Q1 26
4.2%
Q4 25
3.6%
Q3 25
10.6%
25.7%
Q2 25
8.2%
Q1 25
-0.1%
Q4 24
5.7%
Q3 24
8.7%
-53.7%
Q2 24
6.9%
EPS (diluted)
CLB
CLB
GLNG
GLNG
Q1 26
$0.11
Q4 25
$0.11
Q3 25
$0.30
Q2 25
$0.22
Q1 25
$0.00
Q4 24
$0.15
Q3 24
$0.25
Q2 24
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
GLNG
GLNG
Cash + ST InvestmentsLiquidity on hand
$22.8M
$611.2M
Total DebtLower is stronger
$1.9B
Stockholders' EquityBook value
$275.1M
$1.9B
Total Assets
$587.7M
$4.7B
Debt / EquityLower = less leverage
1.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
GLNG
GLNG
Q1 26
$22.8M
Q4 25
$22.7M
Q3 25
$25.6M
$611.2M
Q2 25
$31.2M
Q1 25
$22.1M
Q4 24
$19.2M
Q3 24
$21.5M
$732.1M
Q2 24
$17.7M
Total Debt
CLB
CLB
GLNG
GLNG
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
$1.9B
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
$1.4B
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
GLNG
GLNG
Q1 26
$275.1M
Q4 25
$266.0M
Q3 25
$271.3M
$1.9B
Q2 25
$261.3M
Q1 25
$253.4M
Q4 24
$246.6M
Q3 24
$250.7M
$2.0B
Q2 24
$240.3M
Total Assets
CLB
CLB
GLNG
GLNG
Q1 26
$587.7M
Q4 25
$584.0M
Q3 25
$591.4M
$4.7B
Q2 25
$602.1M
Q1 25
$591.5M
Q4 24
$585.1M
Q3 24
$600.5M
$4.3B
Q2 24
$597.8M
Debt / Equity
CLB
CLB
GLNG
GLNG
Q1 26
Q4 25
0.41×
Q3 25
0.42×
1.01×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
0.70×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
GLNG
GLNG
Operating Cash FlowLast quarter
$4.0M
$149.0M
Free Cash FlowOCF − Capex
$517.0K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.77×
4.73×
TTM Free Cash FlowTrailing 4 quarters
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
GLNG
GLNG
Q1 26
$4.0M
Q4 25
$7.9M
Q3 25
$8.5M
$149.0M
Q2 25
$13.9M
Q1 25
$6.7M
Q4 24
$20.6M
Q3 24
$13.1M
$62.6M
Q2 24
$17.1M
Free Cash Flow
CLB
CLB
GLNG
GLNG
Q1 26
$517.0K
Q4 25
$5.0M
Q3 25
$6.5M
Q2 25
$10.4M
Q1 25
$3.9M
Q4 24
$17.4M
Q3 24
$10.4M
Q2 24
$14.3M
FCF Margin
CLB
CLB
GLNG
GLNG
Q1 26
0.4%
Q4 25
3.6%
Q3 25
4.8%
Q2 25
8.0%
Q1 25
3.1%
Q4 24
13.4%
Q3 24
7.7%
Q2 24
10.9%
Capex Intensity
CLB
CLB
GLNG
GLNG
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
2.7%
Q1 25
2.3%
Q4 24
2.5%
Q3 24
2.0%
Q2 24
2.2%
Cash Conversion
CLB
CLB
GLNG
GLNG
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
4.73×
Q2 25
1.31×
Q1 25
Q4 24
2.78×
Q3 24
1.12×
Q2 24
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons